Head To Head Hot StocksSTORE Capital Corporation (NYSE:STOR), Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

nyse

STORE Capital Corporation (NYSE:STOR)

STORE Capital Corporation (NYSE:STOR) closed at $39.3 on the last trading session with an increase of 0.64%, whereas, it previously closed at $39.05. The company has a market capitalization of $9.21 Billion. The company traded shares of 1.53 Million on the trading day while its three month average volume stands at 1.72 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of STORE Capital Corporation (NYSE:STOR) produced diluted EPS of 1.17. The EPS estimate for next year as estimated by analysts is at 1 while EPS for next quarter is estimated at 0.24. Earnings per Share growth for this year is reported at 22.2, while the analysts estimated the EPS growth for next year at 1% and Earnings growth for next 5 years stands at 6.09% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 33.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of STORE Capital Corporation (NYSE:STOR) is at 33.5 while the forward p/e is at 39.5. The P/S or Price to Sales ratio of STORE Capital Corporation (NYSE:STOR) stands at 14.42 and Price to Book or P/B for the most recent quarter stands at 2.12. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of STORE Capital Corporation (NYSE:STOR) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for STORE Capital Corporation (NYSE:STOR) stands at 3.7, 6.9 and 4.3 respectively

The trailing twelve month Revenue of STORE Capital Corporation (NYSE:STOR) is reported at 639 Million with income of 266.5 Million. The outstanding shares of STORE Capital Corporation (NYSE:STOR) are 234.39 Million. The institutional Ownership of the shares of 97.8 stands at 0.80%, this figure is increased 5.18 in the last six months. The insider ownership for the shares of STORE Capital Corporation (NYSE:STOR) is ticked at 0.5%, the figure is rose 1.03% in the last six months.

Some other important financial aspects to be discussed here for STORE Capital Corporation (NYSE:STOR) is the Mean Target Price estimated by the analysts which stands at 41.35. The 52 week high of STORE Capital Corporation (NYSE:STOR) is placed at 40.96 and 52 week low is standing at 31.34.

Performance wise the shares of STORE Capital Corporation (NYSE:STOR) fell down -1.18% for the week, it also rise 5% for the monthly performance, while for the quarter it went down 0.87%. The shares increase 9.26% for the half year and flew up for the Year-To-Date performance. The shares of STORE Capital Corporation (NYSE:STOR) grew 23.31% for the yearly performance.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) closed at $41.05 on the last trading session with an decrease of -3.21%, whereas, it previously closed at $42.41. The company has a market capitalization of $4.24 Billion. The company traded shares of 922461 on the trading day while its three month average volume stands at 2.48 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) produced diluted EPS of 0.54. The EPS estimate for next year as estimated by analysts is at -0.39 while EPS for next quarter is estimated at -0.04. Earnings per Share growth for this year is reported at 205.9, while the analysts estimated the EPS growth for next year at -0.39% and Earnings growth for next 5 years stands at 7.33% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 20.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is at 76.3 while the forward p/e is at 0. The P/S or Price to Sales ratio of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) stands at 25.93 and Price to Book or P/B for the most recent quarter stands at 7.97. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) are reported at 6.9 and 6.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) stands at 13.2, 18.2 and 24.9 respectively

The trailing twelve month Revenue of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is reported at 163.6 Million with income of 53.3 Million. The outstanding shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) are 103.34 Million. The institutional Ownership of the shares of 66.8 stands at 0.80%, this figure is decreased -1.43 in the last six months. The insider ownership for the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is ticked at 4.8%, the figure is plummeted -14.47% in the last six months.

Some other important financial aspects to be discussed here for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is the Mean Target Price estimated by the analysts which stands at 68.57. The 52 week high of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is placed at 73.72 and 52 week low is standing at 17.05.

Performance wise the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) fell down -0.12% for the week, it also fell -28.61% for the monthly performance, while for the quarter it went up -9.33%. The shares increase 37.84% for the half year and plummeted for the Year-To-Date performance. The shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) grew 137.56% for the yearly performance.